Clinical Trial Update: Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women [Phase 1]

View source ↗

Summary

Phase 1 ascending-dose trial to evaluate safety, tolerability, and pharmacokinetics of BAY1128688 in healthy women, sponsored by Bayer, with Endometriosis liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• BAY1128688

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 1 | Status: COMPLETED